Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.2300
-0.1000
(-7.52%)
At close: April 3 at 4:00:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-123,835
-123,835
-118,686
-138,311
-233,378
Investing Cash Flow
-867
-867
-3,216
-687
-6,673
Financing Cash Flow
97,054
97,054
73,875
-897
267,394
End Cash Position
250,867
250,867
278,598
326,441
466,544
Interest Paid Supplemental Data
15,702
15,702
15,387
10,178
--
Capital Expenditure
-867
-867
-3,216
-687
-6,376
Issuance of Capital Stock
60,506
60,506
--
6,130
--
Issuance of Debt
--
--
--
115,597
49,591
Repayment of Debt
--
--
--
-1,011
-977
Repurchase of Capital Stock
--
--
--
-221
--
Free Cash Flow
-124,702
-124,702
-121,902
-138,998
-239,754
12/31/2021 - 5/18/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNDX Syndax Pharmaceuticals, Inc.
12.46
-3.93%
STRO Sutro Biopharma, Inc.
0.5925
-6.01%
ALEC Alector, Inc.
1.0900
-7.63%
ARVN Arvinas, Inc.
6.90
-3.90%
SYRE Spyre Therapeutics, Inc.
13.99
-9.68%
FDMT 4D Molecular Therapeutics, Inc.
2.8850
-12.04%
KURA Kura Oncology, Inc.
6.17
-5.37%
NKTX Nkarta, Inc.
1.7050
-10.73%
LXEO Lexeo Therapeutics, Inc.
2.6400
-10.36%
ACET Adicet Bio, Inc.
0.6710
-7.32%